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Background: Hereditary hearing loss is a heterogeneous class of disorders showing various patterns of inheritance
and involving many genes. Mutations in the EYA4 gene are responsible for postlingual, progressive, autosomal
dominant hearing loss at the DFNA10 locus.
Methods: We report on a Chinese family with sensorineural, progressive hearing loss. Next-generation sequencing
(NGS) was conducted using DNA samples from this family. A candidate mutation was confirmed by Sanger
sequencing. A detailed genotype and phenotype analysis of EYA4 in deafness is provided.
Results: NGS revealed an insertion mutation c.544_545insA in exon 8 of EYA4 in all affected family members. This
insertion created a frameshift resulting in a stop codon at position 221 (p.F221X). The p.F221X frameshift mutation
cosegregated with hearing loss in the family. Audiograms of affected family members are flat or sloping, differing
from the characteristic “cookie bite” audiogram and the mutation is localized in a different region of the eyaHR
in EYA4.
Conclusions: We identified a novel frameshift mutation in the EYA4 gene. Our results enrich the mutational
spectrum of EYA4 and highlight the complexity of the DFNA10 genotypes and phenotypes. Using NGS techniques
to establish a database of common mutations in patients with hearing loss and further data accumulation will
contribute to the early diagnosis and development of fundamental therapies for hereditary hearing loss.
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Hearing loss is one of the most common perception disor-
ders and a highly heterogeneous sensory disorder. Non-
syndromic hearing loss has both recessive and dominant
modes of inheritance. It is estimated that 80% of the gen-
etic forms of hearing loss are autosomal recessive and the
remaining 20% are autosomal dominant [1]. Autosomal
dominant non-syndromic hearing loss (ADNSHL) is char-
acterized by heterogeneous genetic and clinical features.
To date, more than 60 loci for ADNSHL have been* Correspondence: zqw301@163.com; daipu301@vip.sina.com
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unless otherwise stated.mapped, but only 30 corresponding genes have so far been
identified (http://hereditaryhearingloss.org).
“Classical” genetic studies such as linkage analyses, are
expensive and time-consuming, and it has been difficult
to sequence the hundreds of genes in the candidate
chromosomal loci. Recently, high-throughput sequencing,
also known as next-generation sequencing (NGS) has been
shown to be an ideal tool to overcome these limitations
through its ability to perform parallel sequencing of mil-
lions of nucleotides at relatively low cost and high speed.
The capacity to simultaneously screen thousands of target
genes makes this technique an especially powerful tool for
detecting pathogenic mutations that cause heterogeneous
disorders such as hereditary hearing loss [2].
Among ADNSHL genes, EYA4 was first identified as a
causal gene at DFNA10 by O’Neill in a large American
family in 1996 [3]. All Eya proteins contain a highlyThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 The general structure of EYA4 protein showing the positions of the identified mutation in DFNA10 families (arrows). (N, N-terminus, C,
C-terminus, eyaHR, eya-homologous region, eyaVR, eya-variable region) [5].
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region (eyaHR) and an N-terminal proline-serine-threonine
(PST)-rich transactivation domain known as the eya-
variable region (eyaVR) (Figure 1). The eyaHR is essential
for members of the EYA protein family in terms of their
interaction with PAX, SIX, and DACH proteins in a genetic
network that is conserved across species [4,5]. “Eyes ab-
sent 4” (EYA4), a member of the vertebrate Eya family
of transcriptional activators, is a causative gene of post-
lingual, progressive, autosomal dominant hearing loss at
the DFNA10 locus.
To date, six families at the DFNA10 locus have been
identified. Almost all reported cases show a similar pheno-
type, characterized by postlingual, progressive, “cookie
bite” tonal audiometric curves. In this study, we examined
the genetic basis of ADSHNL in a Chinese family by NGS
and identified a novel mutation, p.F221X, in exon 8 of the
EYA4 gene. The age of onset and audiograms of the af-
fected members in the family also differ from those in pre-
vious reports.Materials and methods
All procedures were approved by the Ethics Reviewing
Committee of the Second Hospital of Hebei Medical
University as well as the Chinese PLA General Hospital.
The study was carried out only after written informedFigure 2 Pedigree diagrams of the family with autosomal dominant hearin
fetus; symbols with dashed line, deceased; arrow indicates the proband).consent was obtained from each individual and/or the
parents of minors.
Family and clinical evaluation
A five-generation hearing loss-affected family of Han origin
from Xinji city in Hebei Province was collected (Figure 2).
In total 15 individuals, 8 affected and 7 unaffected mem-
bers, participated. Detailed medical histories of the family
members were obtained using a questionnaire regarding
the following: subjective degree of hearing loss, age at on-
set, evolution of the hearing loss, presence of tinnitus and
vertigo, history of head trauma and medication with ami-
noglycosides, noise exposure, pathological changes in the
ear, goiter and other relevant clinical manifestations, family
history, and the pregnancy/labor process. Physical exami-
nations ruled out the probability of syndromic hearing loss.
Since neither the deaf patients nor the normal hearing con-
trols in the family reported cardiac discomfort, related ex-
aminations like ECG or ultrasound were not performed.
Hearing was evaluated through otological examinations
and audiological evaluations, including pure-tone audiom-
etry (PTA), immittance, and auditory brainstem response
(ABR). PTA was calculated as an average of the thresholds
measured at 0.5, 1.0, 2.0, and 4.0 kHz. Air-conduction
threshold measurements were performed at 125-8000 Hz
in all participants, and bone-conduction thresholds were
measured at 250-4000 Hz to check conductive hearing lossg loss (Open symbols, unaffected; solid symbols, affected; rhombus,
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scribed as follows depending on PTA: normal hearing,
below 20 dB, mild hearing impairment, 21–40 dB,
moderate hearing impairment, 41–70 dB, severe hearing
impairment, 71–95 dB, and profound hearing impair-
ment, >95 dB. A high-resolution temporal bone CT scan
was performed in affected individuals.
Genomic DNA from the 15 family members and 1000
normal controls was extracted from peripheral blood leuko-
cytes using a commercially available DNA extraction kit
(Qiagen, Hilden, Germany) according to the manufacturer’s
instructions. Ultraviolet spectrophotometry was used to
measure the DNA concentration and purity.
Common deafness gene screening
Mutation screening was conducted using polymerase
chain reaction (PCR) amplification and exons were se-
quenced directly. The common deafness genes included
GJB2, SLC26A4, and the mitochondrial 12S rRNA, and
the primers and PCR conditions for GJB2, SLC26A4, and
the mitochondrial gene were described in detail in our
previous paper [6].
Targeted sequencing and variation analysis
Exons and the flanking 50 bp from 130 known human
deafness genes were selected for capture and NGS se-
quencing using an Illumina HiSeq2000. Hybridization
probes of 0.5 to 1.6 kilobase pairs (kbp) were generated
for these genes from either cDNA clones of the genes or
by PCR amplification from targeted gDNA regions. To en-
sure reliable capture of shorter exons, we specifically gen-
erated longer hybridization probes from gDNA for those
exons that were shorter than 50 bp by including ~100-bp
genomic DNA flanking the exons on both sides. All PCR
products (10 ng each) were purified using the QIAquick
PCR Purification Kit (Qiagen, Valencia, CA, USA) before
use. Further details of the capture probe validation and
preparation can be found in a previous report [7]. Frag-
mented gDNA libraries for Illumina GAII sequencing
were prepared using the NEBNext DNA Sample Prep
Master Mix set (E6040; New England Biolabs, Ipswich,
MA, USA). End repair of DNA fragments, addition of a
3’ adenine (A), adaptor ligation, and reaction clean-up
were performed according to the manufacturer’s proto-
col. The libraries were purified and size-selected using
the AMPure DNA Purification kit (Beckman, Agencourt,
Danvers, MA, USA). The ligated product (20 ng) was
amplified over 14 PCR cycles using the Illumina PCR
primers InPE1.0 and InPE2.0 and indexing primers ac-
cording to the manufacturer’s instructions.
For the targeted enrichment of deafness genes, the
Illumina library DNA was purified using a QIAquick
MinElute column and eluted into 50- μL hybridization buf-
fer (Roche, NimbleGen, Madison, WI, USA). The barcodedIllumina gDNA libraries (5 μg) were incubated in 16-μL
hybridization buffer on the surface of hybridization glass
slides on a hybridization station (BioMicro Systems, Inc.,
Salt Lake City, UT, USA) at 42°C for 72 h. Non-specific
DNA fragments were removed after a series of six wash-
ing steps in washing buffer (Roche). The DNA bound to
the probes was eluted by a 10-min incubation with
NaOH (425 mL, 125 mM). The eluted solution was
transferred to a 1.5-mL microcentrifuge tube containing
500-μL neutralization buffer (Qiagen’s PBI buffer). The
neutralized DNA was desalted and concentrated on a
QIAquick MinElute column and eluted into 30-μL EB
buffer. To increase the yield, we typically amplified 5-μL
eluted solution by 12 cycles of PCR using the Illumina
PCR primers InpE1.0 and 2.0. Enrichment of the tar-
geted deafness genes was examined by comparing the
growth curves of captured and non-captured samples
during quantitative PCR [7]. Twelve barcoded libraries
of captured samples were pooled, and paired-end Illumina
sequencing was performed using the Illumina HiSeq sys-
tem (Illumina, San Diego, CA, USA). Details of the bio-
informatics analysis methods used have been published
previously [7].
Sanger sequencing
Specific exons containing candidate variations were ampli-
fied by PCR using primer sets designed with the Primer3
software (http://www-genome.Wi.mit.edu/cgi-bin/primer/
primer3_www.cgi). Each variation was sequenced by the
Sanger sequencing method using an ABI 3730xl DNA
sequencer (GENEWIZ Biosystems Corps. Beijing, China).
Finally, accurate genotypes of the variations were con-
firmed by sequence analysis using the Sequencing Analysis
software in family members.
Results
Clinical evaluations
The family exhibited a typical autosomal dominant inher-
itance pattern of hearing loss (Figure 2). The reported on-
set of hearing impairment ranged from 20 to 40 years.
The clinical history and audiological assessments of the
eight affected members revealed a form of postlingual, bi-
lateral, symmetrical, progressive, sensorineural hearing
loss that affected both genders (Table 1). The audiogram
patterns from the patients were distinct; in some cases,
such as II-6, all frequencies were affected from the begin-
ning. However, in other cases, such as II-1, high frequen-
cies were affected initially, expanding to all frequencies at
a later stage (Figure 3). Most of affected subjects had tin-
nitus and none had experienced vestibular dysfunction or
other clinical abnormalities indicating syndromic hearing
loss. DPOAE testing in all affected individuals showed
cochlear dysfunction. Temporal bone CT scans of the af-
fected members were normal.
Table 1 Phenotypes and genotypes of the Chinese DFNA family
Member Gender Age (years) Genotype Phenotype
Exon8 (c.544_545insA) Protein (p.F221X) Age of Onset (years) PTA (Left) (dB) PTA (Right) (dB)
II-6 F 74 + + 20 profound 77.5
III-1 M 68 + + 40 83.75 80
III-3 M 61 + + 35 73.75 77.5
III-5 M 56 + + 35 65 71.25
III-8 F 52 — — -- N N
III-11 F 50 + + 30 56.25 57.5
III-13 M 47 + + 30 52.5 52.5
III-15 F 34 — — -- N N
IV-1 M 36 + + 32 36.25 28.75
IV-3 M 31 — — -- N N
IV-5 F 39 — — -- N N
IV-6 M 30 — — -- N N
IV-7 M 25 — — -- N N
IV-9 F 26 — — -- N N
IV-10 M 22 + + 22 40 32.5
(F: female, M:male, +: mutation, —: no mutation, N:normal).
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We analyzed the GJB2, SLC26A4, and mitochondrial 12S
rRNA genes, including c.1494C > T and c.1555A >G. The
results were all negative.
The all 15 individuals were examined by NGS and se-
quenced by the Sanger sequencing method. Variants with
known association with diseases, deleterious functional
impact, and those with low PAF (<0.04) were selected as
candidate mutations for further analysis and validation,
and 20.4 ± 5.4 variants were obtained in each sample. In
targeted sequencing, the c.544_545insA (p.F221X) muta-
tion in the EYA4 gene in exon 8 was identified in this
family (Figure 4). This mutation was verified by Sanger
sequencing. This mutation co-segregated with hearing
loss in patients. The EYA4 c.544_545insA (p.F221X)
was analyzed in 1000 age-matched unrelated random
controls with normal hearing and no carriers of the mu-
tation were identified.
Discussion
Connecting phenotype with genotype is the fundamental
aim of genetics. The purpose of this study was to iden-
tify the genetic basis of hereditary hearing loss using
NGS in the family and to provide genetic counseling to
the family members. Using NGS, we identified a novel
EYA4 mutation, c.544_545insA, in this Chinese family
with ADNSHL. The specific mutaiton, c.544_545insA in
the EYA4 was prioritised due to, 1) The mutaiton co-
segregate with hearing loss in the family, 2) The mutation
was verified by Sanger sequencing in all 15 members and
the results are consistent with those of the NGS, 3) Thespecific mutation was analyzed in 1000 age-matched unre-
lated random controls with normal hearing and no carrier
was identified.
EYA4 is not a frequent gene in ADNSHL, versus other
reported genes. To date, six families have been identified
with ADNSHL linked to the DFNA10 locus (Figure 1
and Table 2). In 1996, O’Neill et al. [3] reported results
of a linkage analysis in a large American family with
ADNSHL, assigning the DFNA10 locus to a 15-cM inter-
val on chromosome 6q22-23. By including distant branches
of the family, they refined the size of the DFNA10 interval
to a 6-cM region [8]. By further study, the group identified
EYA4 gene mutations in two unrelated families from
Belgium and the USA segregating for deafness at this locus;
they found different mutations in EYA4, c.1468insAA
(p.342 fs) and c.2200C >T (p.R587X), both of which create
premature stop codons [5]. A third truncating mutation of
EYA4 in a Hungarian family was revealed with an insertion
of 4 bp (c.1558insTTTG). This insertion creates a frame-
shift and results in a stop codon at position 379 [9]. In
2007, another two new mutations in EYA4 gene were iden-
tified. Makishima et al. [10] identified a novel frameshift
mutation, c.1490insAA, of EYA4 co-segregating with dom-
inant hearing loss at the DFNA10 locus in an American
family. The other was reported by Hildebrand et al. [11], a
novel polypyrimidine tract variation, c.1282-12 T >A, that
introduced a new 3’ splice acceptor site in intron 14. This
was the first report of a point mutation in EYA4 that was
hypothesized to lead to aberrant pre-mRNA splicing and
human disease. More recently, another EYA4 novel muta-
tion, p.I411K, was found by Tan M et al. [12].
Figure 3 Tonal audiometric curves of the affected family members. The audiogram pattern of II-6 (a) branch affected all frequencies from the
beginning, while the branch II-1(b) affected high frequencies initially, expanding to all frequencies at a later stage.
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exon 8 in EYA4, like the previously characterized EYA4
mutations, is predicted to affect the eyaHR domain,
which is important post-developmentally for continued
function of the mature organ of Corti [5,9]. The detected
insertion of 1 bp creates a frameshift at position 182,
resulting in a premature termination codon at position
221 (p.F221X). The effect is either a complete degrad-
ation of the mutant messenger or a nearly complete de-
letion of the eyaHR in the EYA4 protein. We attempted
to construct a three-dimensional structure for the mutant
(p.F221X), but could not because the protein structure
was affected severely. This may also suggest that the novel
mutation is pathogenic rather than a polymorphism. From
our and previous studies, frameshift mutations are com-
mon in the EYA4 gene (Table 2).
The genotype-phenotype correlation of EYA4 was ana-
lyzed. Most of the patients with missense mutations show
bilateral, progressive, sensorineural hearing loss with onset
beginning anywhere from prelingual to slightly above50 years of age, even between members of the same fam-
ily. At onset, hearing loss was mainly in the midfrequen-
cies, with increasing age, all frequencies became
affected. The hearing loss was initially mild, with a
spontaneous evolution to a moderate or severe hearing
impairment [13]. All total audiometric curves of these
family members revealed valley-flat shape, also known
as “cookie bite” curves. Our study shows affected indi-
viduals with ages of onset from 20 to 40 years, later than
previous reports. The impairment initially affected high
frequencies (II-1 branch) or all frequencies (II-6 branch),
which differs from previous reports. Also, the audiograms
of affected members are not characteristic cookie bite
shape but flat or sloping. It is unclear whether this is re-
lated to a regional or ethnic/race origin difference, but this
has not been reported in the previously published families.
In addition to our study, two Chinese ADNSHL fam-
ilies with EYA4 mutations have been reported. In Tan’s
[12] study, a missense mutation, p.I411K, was identified
in EYA4. In that family, the onset of hearing loss was
Figure 4 Part of the sequence of EYA4 in exon 8. (a) Unaffected family member (III-15). (b) showing the heterozygote c.544_545insA mutation,
the arrow indicates the site of insertion in trace. The box indicates the nucleobase difference between wild-type and the mutation.
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onset, hearing impairment was usually mild and detected
in the mid-frequencies, resulting in an audiometric pro-
file commonly referred to as a “cookie-bite” pattern.
Along with progression, hearing loss began to involve
other frequencies. All of these phenotypes were similar
to the previous reports in other populations. Addition-
ally, the reported ages of onset and the audiograms dif-





America 10-50 c.1468insAA p.342 fs eyaHR
Belgium 0-40 c.2200C > T p.R587X eyaHR
Hungary -- c.1558insTTTG p.372 fs eyaHR
America 10-50 c.1490insAA p.349 fs eyaHR
Australia 6-40 c.1282-12 T > A p.426 fs eyaHR
Chinese 8-38 c.T1301A p.I411k eyaHR
Chinese 20-40 c.544_545insA p.F221X eyaHRhearing loss age of onset and audiograms were differed
in the two branches of the family. The audiogram pat-
tern of the II-6 branch affected all frequencies from the
beginning, and the onset age was 20–30 years, while
branch II-1 affected high frequencies initially, expanding
to all frequencies at a later stage, and the age of onset
was later than in branch II-6, about 30–40 years.
Whether these differences are due to environmental fac-




12 valley-flat Wayne (2001) [3,5,8]
20 valley-flat Wayne (2001) [5]
13 valley-flat Pfister (2002) [9]
12 valley-flat Makishima (2007) [10]
Before exon 15 valley-flat Hildebrand (2007) [11]
15 valley-flat Tan M (2014) [12]
8 flat or sloping Our study
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ation in the family and hope to provide them with more
valuable genetic information.
Conclusions
A novel EYA4 mutation, c.544_545insA (p.F221X), was
identified in a Chinese ADNSHL family using NGS and
Sanger sequencing. The phenotype of the family is dif-
fers from the previous reported pedigrees with EYA4
mutations in the age of onset and audiograms. The phe-
notypes also differed between individuals with the same
mutation in the same family. Our results highlight the
complexity of the EYA4 genotype and phenotype.
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